Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
Caris Life Sciences will present eight research posters at the ESMO Congress 2026 in Madrid, October 23-27, 2026. Two Caris-led posters focus on AI-driven treatment prediction and risk stratification in breast cancer, including the CapeAI model, with six additional collaborative studies through the Caris Precision Oncology Alliance spanning breast, lung, endometrial, melanoma and immuno-oncology research.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.